A Call for Open-Source Cost-Effectiveness Analysis
- PMID: 28847014
- PMCID: PMC8269019
- DOI: 10.7326/M17-1153
A Call for Open-Source Cost-Effectiveness Analysis
Conflict of interest statement
Comment in
-
A Call for Open-Source Cost-Effectiveness Analysis.Ann Intern Med. 2018 Apr 3;168(7):528. doi: 10.7326/L17-0693. Ann Intern Med. 2018. PMID: 29610901 No abstract available.
-
A Call for Open-Source Cost-Effectiveness Analysis.Ann Intern Med. 2018 Apr 3;168(7):528-529. doi: 10.7326/L17-0694. Ann Intern Med. 2018. PMID: 29610902 No abstract available.
-
A Call for Open-Source Cost-Effectiveness Analysis.Ann Intern Med. 2018 Apr 3;168(7):529. doi: 10.7326/L17-0695. Ann Intern Med. 2018. PMID: 29610903 No abstract available.
References
-
- Bailey R. Broken science: what happens when cancer doctors, psychologists, and drug developers can't rely on each other's research? Reason. February 2016. Accessed at http://reason.com/archives/2016/01/19/broken-science
-
- Hough J. As drug prices fall, these stocks could rise. Barron's. 15 April 2017. Accessed at www.barrons.com/articles/as-drug-prices-fall-these-stocks-could-rise-149...
-
- Laine C, Goodman SN, Griswold ME, Sox HC. Reproducible research: moving toward research the public can really trust. Ann Intern Med. 2007;146:450–3. [PMID: 17339612] - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous